Skip to main content
Article
Why Primary Patents Covering Biologics Should Be Unforceable against Generic Applicants under the Biologics Price Competition and Innovation Act
Annals of Health Law
  • Yaniv Heled, Georgia State University College of Law
Publication Date
2012
Disciplines
Citation Information
Yaniv Heled. "Why Primary Patents Covering Biologics Should Be Unforceable against Generic Applicants under the Biologics Price Competition and Innovation Act" (2012) p. 211
Available at: http://works.bepress.com/yaniv_heled/2/